Extendicare Stock Fundamentals
| EXE Stock | CAD 10.38 0.04 0.39% |
Extendicare fundamentals help investors to digest information that contributes to Extendicare's financial success or failures. It also enables traders to predict the movement of Extendicare Stock. The fundamental analysis module provides a way to measure Extendicare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Extendicare stock.
At this time, Extendicare's Extraordinary Items is very stable compared to the past year. Extendicare | Select Account or Indicator |
Extendicare Company Operating Margin Analysis
Extendicare's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Extendicare Operating Margin | 0.09 % |
Most of Extendicare's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Extendicare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Extendicare Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Extendicare is extremely important. It helps to project a fair market value of Extendicare Stock properly, considering its historical fundamentals such as Operating Margin. Since Extendicare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Extendicare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Extendicare's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Extendicare Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Extendicare has an Operating Margin of 0.0877%. This is 100.25% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The operating margin for all Canada stocks is 101.59% lower than that of the firm.
Extendicare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Extendicare's current stock value. Our valuation model uses many indicators to compare Extendicare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Extendicare competition to find correlations between indicators driving Extendicare's intrinsic value. More Info.Extendicare is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.12 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Extendicare is roughly 8.38 . At this time, Extendicare's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Extendicare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Extendicare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Extendicare Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in operating margin category among its peers.
Extendicare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Extendicare from analyzing Extendicare's financial statements. These drivers represent accounts that assess Extendicare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Extendicare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 752.4M | 596.3M | 656.9M | 583.9M | 610.2M | 861.8M | |
| Enterprise Value | 1.2B | 981.0M | 1.1B | 800.6M | 868.8M | 1.6B |
Extendicare Fundamentals
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.0716 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.03 B | ||||
| Shares Outstanding | 83.47 M | ||||
| Shares Owned By Insiders | 13.92 % | ||||
| Shares Owned By Institutions | 19.14 % | ||||
| Number Of Shares Shorted | 848.63 K | ||||
| Price To Earning | 26.74 X | ||||
| Price To Book | 7.62 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 1.3 B | ||||
| Gross Profit | 108.53 M | ||||
| EBITDA | 95.19 M | ||||
| Net Income | 33.98 M | ||||
| Cash And Equivalents | 167.28 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 334.52 M | ||||
| Debt To Equity | 6.07 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | 24.07 M | ||||
| Short Ratio | 9.87 X | ||||
| Earnings Per Share | 0.73 X | ||||
| Target Price | 10.5 | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 866.39 M | ||||
| Total Asset | 672.73 M | ||||
| Retained Earnings | (393.47 M) | ||||
| Working Capital | (39.25 M) | ||||
| Current Asset | 211.37 M | ||||
| Current Liabilities | 218.02 M | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 5.98 % | ||||
| Net Asset | 672.73 M |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.4 M | 1.3 M | |
| Total Revenue | 1.3 B | 1.3 B | |
| Cost Of Revenue | 1.2 B | 1.1 B | |
| Sales General And Administrative To Revenue | 0.04 | 0.04 | |
| Capex To Revenue | 0.10 | 0.10 | |
| Revenue Per Share | 15.36 | 22.68 | |
| Ebit Per Revenue | 0.09 | 0.08 |
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving together with Extendicare Stock
Moving against Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.